Horrifying statistics of deaths from the Covid-19 vaccine are emerging. The Office for National Statistics (ONS), the UK’s largest independent producer of official statistics and the UK’s recognized national statistical institute, has released data set shows that between 1 January 2021 and 31 May 2022, a total of 14,103 people died of Covid-19 within 60 days of vaccination, and a total of 166,556 people died of any other cause within 60 days after vaccination. A total of 180,659 people died in England between January 2021 and May 2022 within 60 days of being vaccinated against Covid-19. In Germany, an analysis of government data by two German university professors shows that vaccination against Covid-19 is one factor in excess deaths. SAHPRA’s recent announcement of the country’s second death from Johnson & Johnson’s Covid-19 vaccine could, if the overwhelming evidence in developed countries is any indication, be the start of very tragic events. – Nadia Swart
Janssen’s Covid-19 vaccine update – second death from Guillain-Barré syndrome
On 4 August 2022, SAHPRA issued a media statement regarding the first fatal case of GBS following vaccination with Janssen’s COVID-19 vaccine. SAHPRA was recently informed of a second fatal case of Guillain-Barré syndrome (GBS) following vaccination with Janssen’s COVID-19 vaccine. Causality assessment of the reported case was conducted by the National Immunization Safety Expert Committee (NISEC) using World Health Organization (WHO) methodology. After investigation and causality assessment, this case was classified as a vaccine product-related event. The events reported in the vaccine recipient met the case definition of GBS, and no other probable cause of GBS was identified at the time of illness.
As previously reported, GBS is a very rare but potentially serious neurological adverse event associated with the administration of various vaccines and other drugs, and can also be triggered by certain bacterial or viral infections, including SARS-CoV-2 . Symptoms of GBS range from mild to severe and can include muscle weakness, muscle pain, numbness, and tingling. In many cases, GBS goes away without serious consequences, but in some cases, GBS can cause serious or life-threatening problems.
Regulatory authorities have previously investigated reports of GBS linked to COVID-19 vaccines. They concluded that the Janssen vaccine against COVID-19 may increase the risk of GBS. Therefore, GBS is listed as a rare adverse event in the Professional Information (PI) for Janssen’s COVID-19 Vaccine.
All serious AEs reported with Janssen’s COVID-19 vaccine and other COVID-19 vaccines are under ongoing investigation and causality assessment. The results of these investigations and causation assessments will be released to the public as soon as they are completed.
Important points should be noted
- Vaccines against COVID-19 have consistently been shown to prevent severe disease, hospitalization, and death. Based on the currently available evidence, SAHPRA has determined that the benefits of vaccination against COVID-19 far outweigh the very low risk of serious side effects, including SBS. The public is strongly advised not to delay vaccination against COVID-19 if it is consistent with the national vaccination program.
- SAHPRA encourages the public to report any suspected side effects after using all medicines and vaccines. Reports can be made at the health facility by downloading the Med Safety App (https://medsafety.sahpra.org.za/), available for Android and iOS phones, or by calling the COVID-19 helpline on 0800 029 999. More information AEFIs reported for COVID-19 vaccines and how to report AEFIs can be found on the SAHPRA website: https://aefi-reporting.sahpra.org.za/.
Read also:
(Visited 1 time, 1 visit today)
